The next tech revolution in biotech might save lives, but it could also crush pharmaceutical margins.
Monday U.S. Economic Lookahead U.S. leading economic indicators (June) Featured Earnings ...
As Middle East tensions resurface and futures drop, VIG, VIGI, and FDVV offer dividend growth ETFs combining income with exposure to technology and global equities.
VERAXA Biotech (NASDAQ: VRXA) operates in one of biotechnology’s most active partnering environments, with pharmaceutical companies continuing to commit billions of dollars to differentiated antibody...
Haleon has struck a five-year partnership with Microsoft as it looks to expand its AI transformation using Microsoft's Copilot.
European stocks are outpacing the S&P 500 in 2026, and ArcelorMittal, Arm Holdings, and Novartis are three Euro Stoxx 50 components with index-beating returns.
/AI%20(artificial%20intelligence)/Businessman%20touching%20the%20brain%20working%20of%20Artificial%20Intelligence%20(AI)%20Automation%20by%20Suttiphong%20Chandaeng%20via%20Shutterstock.jpg)
Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.
With U.S. federal debt exceeding 100% of GDP, VXUS and IXUS offer investors international equity exposure as a hedge against rising sovereign risk.
Amgen ($AMGN) is investing an additional $300 million to expand its biologics manufacturing facility in Puerto Rico, bringing its recent commitments to the site to nearly $1 billion as drugmakers increase...
Barchart Research What to Expect from NVS Earnings NVS Generated April 27, 2026 Current Price $144.19 EPS Estimate $$2.11 Consensus Rating Moderate Buy Average Move 2.66% Can Novartis Prove Its Pipeline...